3,302
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Antimicrobial resistance pattern and molecular epidemiology of ESBL and MBL producing Acinetobacter baumannii isolated from hospitals in Minia, Egypt

ORCID Icon, , , & ORCID Icon
Pages 4-13 | Received 19 Jul 2019, Accepted 13 Nov 2019, Published online: 03 Jan 2020

References

  • Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents. 2008 Aug;32(2):106–119.
  • Mishra SK, Rijal BP, Pokhrel BM. Emerging threat of multidrug resistant bugs–acinetobacter calcoaceticus baumannii complex and methicillin resistant Staphylococcus aureus. BMC Res Notes. 2013 Mar;15(6):98.
  • Mahzounieh M, Khoshnood S, Ebrahimi A, et al. Detection of antiseptic-resistance genes in pseudomonas and acinetobacter spp. isolated from burn patients. Jundishapur J Nat Pharm Prod. 2014 May;9(2):e15402.
  • Obeidat N, Jawdat F, Al-Bakri AG, et al. Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients’ respiratory tract sources. Am J Infect Control. 2014 Apr;42(4):401–404.
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008 Jul;21(3):538–582.
  • Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933–951.
  • Naas T, Namdari F, Reglier-Poupet H, et al. Panresistant extended-spectrum beta-lactamase SHV-5-producing Acinetobacter baumannii from New York City. J Antimicrob Chemother. 2007 Nov;60(5):1174–1176.
  • Poirel L, Bonnin RA, Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life. 2011 Dec;63(12):1061–1067.
  • Herellea EC. (Acinetobacter) and Pseudomonas ovalis (P. putida) from frozen foods. Appl Microbiol. 1969 Jan;17(1):26–30.
  • Wayne P. CLSI. Performance Standards for Antimicrobial Susceptibility. 29th ed. CLSI supplement M100. Wayne, PA: Clinical and laboratory Standards Institute; 2019.
  • Nagano N, Nagano Y, Cordevant C, et al. Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol. 2004 Sep;42(9):3978–3984.
  • Noyal MJ, Menezes GA, Harish BN, et al. Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res. 2009 Jun;129(6):707–712.
  • Yong D, Lee K, Yum JH, et al. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002 Oct;40(10):3798–3801.
  • Wilson K. Preparation of genomic DNA from bacteria. Curr Protoc Mol Biol. 1987;56(1):2.4.1–2.4.5
  • Ullah W, Qasim M, Rahman H, et al. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: first report from Pakistan. Microb Pathog. 2017;105:240–244.
  • Ellington MJ, Kistler J, Livermore DM, et al. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother. 2007 Feb;59(2):321–322.
  • Brown S, Young H, Amyes S. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect. 2005;11(1):15–23.
  • Higgins PG, Lehmann M, Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2010;35(3):305.
  • Perez F, Hujer AM, Hujer KM, et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007 Oct;51(10):3471–3484.
  • Safwat D, Abdelwahab SF, Hasanen AM, et al. Prevalence of acinetobacter baumannii at minia university hospital. Egypt J Med Microbiol. 2011;20(1):63–68.
  • Sadeghi P, Khosravi AD, Shahraki AH, et al. Identification of clinical isolates of Acinetobacter baumannii from Iran and study of their heterogeneity. J Chin Med Assoc. 2016;79(7):382–386.
  • Kateete DP, Nakanjako R, Okee M, et al. Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda. BMC Res Notes. 2017;10(1):284.
  • Petrova AP, Stanimirova ID, Ivanov IN, et al. Carbapenemase production of clinical isolates acinetobacter baumannii and pseudomonas aeruginosa from a Bulgarian University Hospital. Folia Med (Plovdiv). 2017;59(4):413–422.
  • Ren G, Zhou M, Ding N, et al. Analysis on distribution features and drug resistance of clinically isolated Acinetobacter baumannii. Exp Ther Med. 2016 Sep;12(3):1715–1718.
  • Djahmi N, Dunyach-Remy C, Pantel A, et al. Epidemiology of carbapenemase-producing enterobacteriaceae and acinetobacter baumannii in Mediterranean Countries. Biomed Res Int. 2014;2014:11.
  • Dias VC, Resende JA, Bastos AN, et al. Epidemiological, physiological, and molecular characteristics of a brazilian collection of carbapenem-resistant acinetobacter baumannii and pseudomonas aeruginosa. Microb Drug Resist. 2017;23(7):852–863.
  • Rossello J, Olona M, Campins M, et al. Investigation of an outbreak of nosocomial infection due to a multiply drug-resistant strain of Pseudomonas aeruginosa. J Hosp Infect. 1992 Feb;20(2):87–96.
  • Nowak P, Paluchowska P, Budak A. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol. 2012 Jul;35(3):317–325.
  • Singh H, Thangaraj P, Chakrabarti A. Acinetobacter baumannii: a brief account of mechanisms of multidrug resistance and current and future therapeutic management. J Clin Diagn Res. 2013 11/10 04/26/received 07/28/rev-request 09/18/accepted;7(11): 2602–2605.
  • Farajnia S, Azhari F, Alikhani MY, et al. Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant acinetobacter baumannii isolates in North-West of Iran. Iran J Basic Med Sci. 2013 Jun;16(6):751–755.
  • Owlia P, Azimi L, Gholami A, et al. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Infez Med. 2012 Sep;20(3):182–187.
  • Jones RN, Biedenbach DJ, Sader HS, et al. Emerging epidemic of metallo-beta-lactamase-mediated resistances. Diagn Microbiol Infect Dis. 2005 Feb;51(2):77–84.
  • Anwar M, Ejaz H, Zafar A, et al. Phenotypic detection of metallo-beta-lactamases in carbapenem resistant acinetobacter baumannii isolated from pediatric patients in Pakistan. J Pathog. 2016;2016:8603964.
  • Easwaran S, Ramasamy R. Prevalence of metallo β lactamases producing pseudomonas spp. and acinetobacter spp. in a tertiary care teaching hospital. J Drug Discovery Ther. 2017;5(7):35–39.
  • Shahcheraghi F, Abbasalipour M, Feizabadi M, et al. Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011 Jun;3(2):68–74.
  • Woodford N, Ellington MJ, Coelho JM, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006 Apr;27(4):351–353.
  • Higgins PG, Poirel L, Lehmann M, et al. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009 Dec;53(12):5035–5038.
  • Neves FC, Clemente WT, Lincopan N, et al. Clinical and microbiological characteristics of OXA-23- and OXA-143-producing Acinetobacter baumannii in ICU patients at a teaching hospital, Brazil. Braz J Infect Dis. 2016 Nov 01;20(6):556–563.
  • Antonio CS, Neves PR, Medeiros M, et al. High prevalence of carbapenem-resistant Acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals. Antimicrob Agents Chemother. 2011 Mar;55(3):1322–1323.
  • Mostachio AK, Levin AS, Rizek C, et al. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil. Int J Antimicrob Agents. 2012 May;39(5):396–401.
  • Hakemi Vala M, Hallajzadeh M, Hashemi A, et al. Detection of Ambler class A, B and D ss-lactamases among Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from burn patients. Ann Burns Fire Disasters. 2014 Mar 31;27(1):8–13.
  • Kazi M, Nikam C, Shetty A, et al. Dual-tubed multiplex-PCR for molecular characterization of carbapenemases isolated among Acinetobacter spp. and Pseudomonas spp. J Appl Microbiol. 2015 May;118(5):1096–1102.
  • Amudhan MS, Sekar U, Kamalanathan A, et al. bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India. J Infect Dev Ctries. 2012 Nov 26;6(11):757–762.
  • Safari M, Mozaffari Nejad AS, Bahador A, et al. Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU). Saudi J Biol Sci. 2015 Jul;22(4):424–429.
  • Erfani Y, Yaghuobi S, Fallah F, et al. Detection of bla NDM-, bla VIM, and bla IMP genes in multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa from clinical isolates in Tehran hospitals. Int J Adv Biotechnol Res. 2017;8(2):500–506.